Pioglitazone
Product manufactured by Sandoz Inc
Indications and Purposes
| 1 Indications And Usage Monotherapy And Combination Therapy Pioglitazone Tablets Are Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus In Multiple Clinical Settings [See Clinical Studies ( 14 )]. Important Limitations Of Use Pioglitazone Tablets Exerts Its Antihyperglycemic Effect Only In The Presence Of Endogenous Insulin. Pioglitazone Tablets Should Not Be Used To Treat Type 1 Diabetes Or Diabetic Ketoacidosis, As It Would Not Be Effective In These Settings. Use Caution In Patients With Liver Disease [ See Warnings And Precautions ( 5.3 )]. Pioglitazone Tablets Are A Thiazolidinedione And An Agonist For Peroxisome Proliferator-Activated Receptor (Ppar) Gamma Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus In Multiple Clinical Settings. ( 1 , 14 ) Important Limitations Of Use: • Not For Treatment Of Type 1 Diabetes Or Diabetic Ketoacidosis. ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Pioglitazone Hydrochloride |
|
ZINC968326 |